Send to:

Choose Destination
See comment in PubMed Commons below
J Neuroimmunol. 2012 Jan 18;242(1-2):52-9. doi: 10.1016/j.jneuroim.2011.11.005. Epub 2011 Dec 6.

Immune profiling of Alzheimer patients.

Author information

  • 1Department of Internal Medicine II, Center for Medical Research, University of Tübingen, Tübingen Aging and Tumor Immunology group, Waldhörnlestr. 22, 72072 Tübingen, Germany.


Alzheimer's disease (AD) is characterized by extracellular senile plaques in the brain, containing amyloid-β peptide (Aβ). We identify immunological differences between AD patients and age-matched controls greater than those related to age itself. The biggest differences were in the CD4+ rather than the CD8+ T cell compartment resulting in lower proportions of naïve cells, more late-differentiated cells and higher percentages of activated CD4+CD25+ T cells without a Treg phenotype in AD patients. Changes to CD4+ cells might be the result of chronic stimulation by Aβ present in the blood. These findings have implications for diagnosis and understanding the aetiology of the disease.

Copyright © 2011 Elsevier B.V. All rights reserved.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk